Cite

    Samar Abu Rkhaya et al.. “Increased malondialdehyde vs. reduced sirtuin 1 in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes.” Diabetes & metabolic syndrome, vol. 12, no. 6, 2018, pp. 903–909. http://access.bl.uk/ark:/81055/vdc_100066659389.0x000010